Human Genome Project — $14.5B federal investment 1988-2012 → $965B economic impact

Federal investment in the Human Genome Project and subsequent genomics research totaled $14.5 billion from 1988 through 2012 and generated $965 billion in economic impact (S-0111) — a return of approximately 66:1.

The case is among the strongest available anchors for the open-data multiplier. The HGP's defining policy decision was to release the reference genome openly into the public domain. The downstream impact compounded across pharmaceutical R&D, agricultural genomics, evolutionary biology, and medical diagnostics — each application building on the same openly available reference.

Within the C-0032 framework, the HGP demonstrates that the open-access multiplier scales to multi-decade horizons. The $965B impact figure measures returns out to ~25 years from initial investment; the architectural property the paper recommends (Tier 3 preservation that does not truncate at the grant cycle) is what made that timescale possible. Closed-access alternatives that truncated at funding renewal would have produced a fundamentally different impact curve.